ACADIA PHARMACEUTICALS INC (ACAD) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: -$45.47M2010: $15.09M2011: -$22.85M2012: -$20.89M2013: -$38.30M2014: -$93.23M2015: -$164.61M2016: -$272.81M2017: -$292.41M2018: -$247.44M2019: -$246.54M2020: -$286.59M2021: -$170.44M2022: -$223.60M2023: -$73.38M2024: $230.79M2025: $104.81M$104.81M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$104.81M-54.6%
2024$230.79M+414.5%
2023-$73.38M+67.2%
2022-$223.60M-31.2%
2021-$170.44M+40.5%
2020-$286.59M-16.2%
2019-$246.54M+0.4%
2018-$247.44M+15.4%
2017-$292.41M-7.2%
2016-$272.81M-65.7%
2015-$164.61M-76.6%
2014-$93.23M-143.4%
2013-$38.30M-83.4%
2012-$20.89M+8.6%
2011-$22.85M-251.4%
2010$15.09M+133.2%
2009-$45.47M